DYAI Dyadic International Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DYAI

Price (delayed)

$1.43

Market cap

$41.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.24

Enterprise value

$35.05M

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica (formerly ...

Highlights
DYAI's gross margin has surged by 50% since the previous quarter and by 16% year-on-year
The company's gross profit rose by 47% QoQ and by 14% YoY
The EPS has increased by 29% YoY but it has decreased by 4.3% QoQ
DYAI's equity is down by 47% YoY and by 23% QoQ
DYAI's quick ratio is down by 42% since the previous quarter and by 35% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.dyadic.com
Peers: DD CDXS TMO

Key stats

What are the main financial stats of DYAI
Market
Shares outstanding
28.97M
Market cap
$41.43M
Enterprise value
$35.05M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.01
Price to sales (P/S)
14.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.09
Earnings
Revenue
$2.9M
EBIT
-$6.8M
EBITDA
-$6.8M
Free cash flow
-$6.73M
Per share
EPS
-$0.24
Free cash flow per share
-$0.23
Book value per share
$0.2
Revenue per share
$0.1
TBVPS
$0.29
Balance sheet
Total assets
$8.22M
Total liabilities
$2.34M
Debt
$136,929
Equity
$5.88M
Working capital
$5.82M
Liquidity
Debt to equity
0.02
Current ratio
3.58
Quick ratio
3.43
Net debt/EBITDA
0.94
Margins
EBITDA margin
-234.4%
Gross margin
31.8%
Net margin
-234.4%
Operating margin
-282.6%
Efficiency
Return on assets
-65.7%
Return on equity
-81.6%
Return on invested capital
-342.9%
Return on capital employed
-113.9%
Return on sales
-234.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DYAI stock price

How has the Dyadic International stock price performed over time
Intraday
-4.67%
1 week
-4.03%
1 month
-21.43%
1 year
-18.29%
YTD
-11.18%
QTD
-14.37%

Financial performance

How have Dyadic International's revenue and profit performed over time
Revenue
$2.9M
Gross profit
$922,957
Operating income
-$8.19M
Net income
-$6.8M
Gross margin
31.8%
Net margin
-234.4%
DYAI's gross margin has surged by 50% since the previous quarter and by 16% year-on-year
The company's gross profit rose by 47% QoQ and by 14% YoY
The net income has grown by 30% YoY
Dyadic International's net margin has increased by 29% YoY

Growth

What is Dyadic International's growth rate over time

Valuation

What is Dyadic International stock price valuation
P/E
N/A
P/B
7.01
P/S
14.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.09
The EPS has increased by 29% YoY but it has decreased by 4.3% QoQ
DYAI's equity is down by 47% YoY and by 23% QoQ
DYAI's price to book (P/B) is 25% higher than its 5-year quarterly average of 5.6 and 8% higher than its last 4 quarters average of 6.5
The stock's price to sales (P/S) is 76% less than its 5-year quarterly average of 59.3 and 14% less than its last 4 quarters average of 16.6

Efficiency

How efficient is Dyadic International business performance
Dyadic International's return on invested capital has shrunk by 78% YoY and by 72% QoQ
The ROS has increased by 29% YoY
The ROE has declined by 14% since the previous quarter and by 12% year-on-year
Dyadic International's return on assets has decreased by 12% QoQ and by 9% YoY

Dividends

What is DYAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DYAI.

Financial health

How did Dyadic International financials performed over time
Dyadic International's total liabilities has increased by 46% from the previous quarter but it has decreased by 11% YoY
Dyadic International's current ratio has decreased by 43% from the previous quarter and by 35% YoY
Dyadic International's debt is 98% less than its equity
DYAI's equity is down by 47% YoY and by 23% QoQ
Dyadic International's debt has decreased by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.